Bridgeway Capital Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-155,375
| Closed | -$120K | – | 1469 |
|
|
2022
Q2 | $120K | Sell |
155,375
-14,525
| -9% | -$11.2K | ﹤0.01% | 1195 |
|
|
2022
Q1 | $182K | Hold |
169,900
| – | – | ﹤0.01% | 1186 |
|
|
2021
Q4 | $323K | Sell |
169,900
-26,000
| -13% | -$49.4K | 0.01% | 1087 |
|
|
2021
Q3 | $590K | Hold |
195,900
| – | – | 0.01% | 987 |
|
|
2021
Q2 | $766K | Buy |
195,900
+80,000
| +69% | +$313K | 0.01% | 942 |
|
|
2021
Q1 | $588K | Hold |
115,900
| – | – | 0.01% | 1048 |
|
|
2020
Q4 | $474K | Hold |
115,900
| – | – | 0.01% | 966 |
|
|
2020
Q3 | $563K | Hold |
115,900
| – | – | 0.01% | 842 |
|
|
2020
Q2 | $642K | Buy |
115,900
+35,000
| +43% | +$194K | 0.01% | 789 |
|
|
2020
Q1 | $265K | Sell |
80,900
-22,400
| -22% | -$73.4K | 0.01% | 966 |
|
|
2019
Q4 | $467K | Hold |
103,300
| – | – | 0.01% | 1019 |
|
|
2019
Q3 | $430K | Hold |
103,300
| – | – | 0.01% | 1011 |
|
|
2019
Q2 | $392K | Buy |
103,300
+20,000
| +24% | +$75.9K | 0.01% | 1038 |
|
|
2019
Q1 | $349K | Sell |
83,300
-43,400
| -34% | -$182K | ﹤0.01% | 1124 |
|
|
2018
Q4 | $315K | Hold |
126,700
| – | – | ﹤0.01% | 1119 |
|
|
2018
Q3 | $925K | Sell |
126,700
-25,000
| -16% | -$183K | 0.01% | 912 |
|
|
2018
Q2 | $561K | Buy |
151,700
+55,000
| +57% | +$203K | 0.01% | 1095 |
|
|
2018
Q1 | $372K | Buy |
96,700
+4,300
| +5% | +$16.5K | ﹤0.01% | 1160 |
|
|
2017
Q4 | $333K | Hold |
92,400
| – | – | ﹤0.01% | 1190 |
|
|
2017
Q3 | $365K | Hold |
92,400
| – | – | ﹤0.01% | 1169 |
|
|
2017
Q2 | $471K | Sell |
92,400
-42,600
| -32% | -$217K | 0.01% | 1104 |
|
|
2017
Q1 | $932K | Buy |
135,000
+90,000
| +200% | +$621K | 0.01% | 837 |
|
|
2016
Q4 | $421K | Buy |
+45,000
| New | +$421K | 0.01% | 1136 |
|